Immunomodulation | Pharmacokinetics & Drug Delivery | Drug Discovery & Design | Immunopharmacology & Hematologic Pharmacology | Toxicology | Clinical Immunology | Methods for Diagnostic & Therapeutic Studies
Comparative local tolerability of IgPro20, a new 20% immunoglobulin preparation for subcutaneous administration
Othmar Zenker*, Irmgard Andresen
*Corresponding author: Othmar Zenker
CSL Behring GmbH, Marburg, Germany
F1000Posters 2011, 2: 898 (poster) [Arabic]
Poster [940.31 KB]
American Academy of Allergy, Asthma and Immunology Annual Meeting 2010, 26 Feb - 2 Mar 2010, 556
To explore the effects (if any) on local tolerability of an increase in subcutaneous immune globulin (SCIG) concentration from 16% to 20% by comparing 4 different combinations of stabilizer, IgG content, and infusion volume.
The tolerability of 20% SCIG is not worse than that of 16% SCIG.
Authors Othmar Zenke and Irmgard Andresen are paid employees of CSL Behring.
Please note that most posters on this site present work that is preliminary in nature and has not been peer reviewed.
This poster is open access subject to the CC BY-NC Creative Commons 3.0 License